CorVel (CRVL) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Nov, 2025Executive summary
Quarterly revenue rose 7% year-over-year to $240 million, driven by network solutions and organic growth.
Diluted EPS increased 20% to $0.54, adjusted for a three-for-one stock split.
Net income for the quarter was $28 million, up from $23 million in the prior year.
Company completed a technology acquisition to enhance bill review and AI initiatives.
Investments in workforce development and AI-driven operational enhancements continue.
Financial highlights
Gross profit for the quarter was $58.2 million, up 15% year-over-year, with gross margin improving to 24.3%.
Net income for the quarter reached $27.9 million, with six-month net income at $55.1 million.
Quarter-ending cash balance stood at $207 million, with no borrowings.
Day sales outstanding improved to 40 days, a two-day reduction year-over-year.
General and administrative expenses were $22.3 million, representing 9.3% of revenue.
Outlook and guidance
Continued focus on leveraging AI and automation to drive operational efficiency and partner savings.
Expansion of offerings and technological capabilities through organic growth and targeted M&A.
Management expects G&A expenses to remain between 9% and 11% of revenues.
Current cash and cash flow from operations expected to fund growth and obligations for at least 12 months.
Forward-looking statements are subject to risks, including labor market and technology adoption.
Latest events from CorVel
- Revenue and EPS rose, with AI-driven efficiency and strong cash supporting growth.CRVL
Q3 20265 Feb 2026 - Technology-driven care management and financial strength position the firm as a top industry innovator.CRVL
Investor presentation3 Feb 2026 - Revenue up 11.3% and EPS up 10% as AI and new accounts drive growth and efficiency.CRVL
Q1 20252 Feb 2026 - Revenue up 13% and EPS up 39% year-over-year, with strong cash and AI-driven efficiency.CRVL
Q3 20259 Jan 2026 - Director elections, auditor ratification, and a new stock plan headline a governance-focused agenda.CRVL
Proxy Filing1 Dec 2025 - Six directors and the external auditor are up for shareholder vote at the August 2024 meeting.CRVL
Proxy Filing1 Dec 2025 - Shareholders will elect six directors and ratify the auditor, with a focus on governance and diversity.CRVL
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and a new stock incentive plan.CRVL
Proxy Filing1 Dec 2025 - Double-digit revenue and EPS growth, expanded AI operations, and a debt-free balance sheet.CRVL
Q4 202524 Nov 2025